Details for New Drug Application (NDA): 088051
✉ Email this page to a colleague
NDA 088051 describes THALITONE, which is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the THALITONE profile page.
The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Summary for 088051
| Tradename: | THALITONE |
| Applicant: | Monarch Pharms |
| Ingredient: | chlorthalidone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088051
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Nov 12, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
